Clopidogrel Tablets Recalled Due to Simvastatin Labeling Error
International Laboratories, LLC is recalling Clopidogrel Tablets 75 mg because bottles were found containing Simvastatin Tablets 10 mg.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The agency classification is FDA Class I, which is defined as a situation where use of or exposure to the product may cause serious adverse health consequences or death.
Plain-English summary
International Laboratories, LLC is recalling Clopidogrel Tablets, USP 75 mg, 30-count bottles. The recall is due to a labeling mix-up where Simvastatin tablets, USP 10 mg were found in bottles labeled as Clopidogrel tablets, USP 75 mg.
The affected product is identified by Lot # 117099A and an expiration date of 08/19. The NDC number is 54458-888-16. A total of 218,772 bottles were distributed nationwide within the US.
Consumers should check their medication bottles for this specific lot number and expiration date. If the product matches the description, they should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining the correct medication.
The recalled product
- Product
- Clopidogrel Tablets, USP 75 mg, 30-count bottles, Rx only, Packaged for: International Laboratories, LLC St. Petersburg, FL 33710, NDC 54458-888-16
- Manufacturer
- International Laboratories, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 218,772
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 117099A
- Exp. 08/19
Distribution
Distributed nationwide across the United States.
Related recalls
Same hazard · mis labeling
See all →- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- HighByron White A-L Complex Herbal Supplement Recalled for Undeclared Walnut
FDA (Food) · 2026-09-02
- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02